Dario publishes two new peer-reviewed studies demonstrating impact of digital behavioral health

Studies include a randomized controlled trial demonstrating significant reduction in perceived stress for teens new york , april 10, 2024 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today two new studies published in the leading peer-reviewed journal for digital health and medicine, journal of internet medicine (jmir), including a randomized controlled trial (rct) demonstrating the impact of a digital stress reduction program for teens. digital tools reduce stress and brooding in teens in a randomized control trial the first study uses the gold standard in research, a randomized controlled clinical trial (rct), to demonstrate the impacts of a self-guided digital mental health intervention (dmhi) for teens.
DRIO Ratings Summary
DRIO Quant Ranking